Online inquiry

IVTScrip™ mRNA-Human ABHD14A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK14163MR)

This product GTTS-WK14163MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ABHD14A protein. This product can be used in Retinoid acid signaling-responsive fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_015407.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 25864
UniProt ID Q9BUJ0
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ABHD14A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK14163MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK17569MR IVTScrip™ mRNA-Human ANAPC15, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANAPC15
GTTS-WK23038MR IVTScrip™ mRNA-Human ATAD3A, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ATAD3A
GTTS-WK23338MR IVTScrip™ mRNA-Human ATAD3A, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ATAD3A
GTTS-WK14325MR IVTScrip™ mRNA-Human ADCYAP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADCYAP1
GTTS-WK3157MR IVTScrip™ mRNA-Human PBLD, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA PBLD
GTTS-WK19621MR IVTScrip™ mRNA-Human ALK6, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ALK6
GTTS-WK23830MR IVTScrip™ mRNA-Human ARIH2, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARIH2
GTTS-WK1580MR IVTScrip™ mRNA-Human CD156b, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA CD156b
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW